Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
1.390
+0.260 (23.01%)
At close: Oct 27, 2026, 4:00 PM EDT
1.430
+0.040 (2.88%)
Pre-market: Oct 28, 2026, 7:00 AM EDT
Pomdoctor Revenue
Pomdoctor had revenue of 185.00M CNY in the half year ending June 30, 2026, with 23.20% growth. This brings the company's total for the last twelve months to 410.45M, up 11.88% year-over-year. In the year 2025, Pomdoctor had annual revenue of 399.91M with 16.74% growth. That makes Pomdoctor the 26,522nd largest company in the world by revenue and 3,638th in the United States.
Revenue (ttm)
410.45M CNY
Revenue Growth
+11.88%
P/S Ratio
0.06
Revenue / Employee
2,487,548 CNY
Employees
165
Market Cap
3.86M USD
Revenue by Segment
- Pharmaceutical Supply Chain 249.20M 62.3%
- Internet Hospital 150.71M 37.7%
Fiscal year ended Dec 31, 2025 See the full Pomdoctor breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 399.91M | 57.36M | 16.74% |
| Dec 31, 2024 | 342.56M | 37.70M | 12.37% |
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | 29.83M | 13.85% |
| Dec 31, 2021 | 215.38M | 74.18M | 52.53% |
| Dec 31, 2020 | 141.21M | -44.33M | -23.89% |
| Dec 31, 2019 | 185.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.06B |
| Johnson & Johnson | 99.34B |
| Eli Lilly and Company | 79.67B |
| AbbVie | 64.39B |
| cbdMD | 20.93M |
| bioAffinity Technologies | 5.90M |
| Co-Diagnostics | 721.39K |
POM News
- 7 days ago - PomDoctor Ltd – ADR trading halted, news pending - TheFly
- 8 days ago - PomDoctor announces termination of ADR program, share consolidation - TheFly
- 8 days ago - POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq - PRNewsWire
- 15 days ago - POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare - PRNewsWire
- 18 days ago - PomDoctor receives noncompliance notification from Nasdaq - TheFly
- 18 days ago - POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination - PRNewsWire
- 27 days ago - POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization - PRNewsWire
- 4 weeks ago - POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model - PRNewsWire